Team1 (vB_SauM_Team1) is a polyvalent staphylococcal phage belonging to the Myoviridae family. Phage Team1 was propagated on a Staphylococcus aureus strain and a non-pathogenic Staphylococcus xylosus strain used in industrial meat fermentation. The two Team1 preparations were compared with respect to their microbiological and genomic properties. The burst sizes, latent periods, and host ranges of the two derivatives were identical as were their genome sequences. Phage Team1 has 140,903 bp of double stranded DNA encoding for 217 open reading frames and 4 tRNAs. Comparative genomic analysis revealed similarities to staphylococcal phages ISP (97%) and G1 (97%). The host range of Team1 was compared to the well-known polyvalent staphylococcal ph...
The increase in antibiotic resistance in pathogenic bacteria is a public health danger requiring alt...
Phage therapy is a promising option for fighting against staphylococcal infections. Two lytic phages...
Phage therapy recently passed a key milestone with success of the first regulated clinical trial usi...
Team1 (vB_SauM_Team1) is a polyvalent staphylococcal phage belonging to the Myoviridae family. Phage...
Team1 (vB_SauM_Team1) is a polyvalent staphylococcal phage belonging to the Myoviridae family. Phage...
Team1 (vB_SauM_Team1) is a polyvalent staphylococcal phage belonging to the Myoviridae family. Phage...
<div><p>Team1 (vB_SauM_Team1) is a polyvalent staphylococcal phage belonging to the <i>Myoviridae</i...
Team1 (vB_SauM_Team1) is a polyvalent staphylococcal phage belonging to the Myoviridae family. Phage...
Trabajo presentado en la conference Viruses of Microbes, celebrada en Liverpool (Reino Unido) del 18...
Staphylococcus aureus is a very successful opportunistic pathogen capable of causing a variety of di...
Staphylococcus aureus is a commensal and pathogenic bacterium that causes infections in humans and a...
Emergence of antibiotic-resistant bacteria is a serious threat to the public health. This is also tr...
The increase in antibiotic resistance in pathogenic bacteria is a public health danger requiring alt...
Phage therapy recently passed a key milestone with success of the first regulated clinical trial usi...
The increase in antibiotic resistance in pathogenic bacteria is a public health danger requiring alt...
The increase in antibiotic resistance in pathogenic bacteria is a public health danger requiring alt...
Phage therapy is a promising option for fighting against staphylococcal infections. Two lytic phages...
Phage therapy recently passed a key milestone with success of the first regulated clinical trial usi...
Team1 (vB_SauM_Team1) is a polyvalent staphylococcal phage belonging to the Myoviridae family. Phage...
Team1 (vB_SauM_Team1) is a polyvalent staphylococcal phage belonging to the Myoviridae family. Phage...
Team1 (vB_SauM_Team1) is a polyvalent staphylococcal phage belonging to the Myoviridae family. Phage...
<div><p>Team1 (vB_SauM_Team1) is a polyvalent staphylococcal phage belonging to the <i>Myoviridae</i...
Team1 (vB_SauM_Team1) is a polyvalent staphylococcal phage belonging to the Myoviridae family. Phage...
Trabajo presentado en la conference Viruses of Microbes, celebrada en Liverpool (Reino Unido) del 18...
Staphylococcus aureus is a very successful opportunistic pathogen capable of causing a variety of di...
Staphylococcus aureus is a commensal and pathogenic bacterium that causes infections in humans and a...
Emergence of antibiotic-resistant bacteria is a serious threat to the public health. This is also tr...
The increase in antibiotic resistance in pathogenic bacteria is a public health danger requiring alt...
Phage therapy recently passed a key milestone with success of the first regulated clinical trial usi...
The increase in antibiotic resistance in pathogenic bacteria is a public health danger requiring alt...
The increase in antibiotic resistance in pathogenic bacteria is a public health danger requiring alt...
Phage therapy is a promising option for fighting against staphylococcal infections. Two lytic phages...
Phage therapy recently passed a key milestone with success of the first regulated clinical trial usi...